Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.0194
Abstract: Key Points Question Is concomitant use of oxycodone with selective serotonin reuptake inhibitors (SSRIs) that are potent inhibitors of oxycodone metabolism via the cytochrome-P450 2D6 (CYP2D6) enzyme (fluoxetine and paroxetine) associated with opioid overdose? Findings… read more here.
Keywords: concomitant use; opioid overdose; risk opioid; use oxycodone ... See more keywords
Concomitant use of benzodiazepines and opioids in community‐dwelling older people with or without Alzheimer's disease—A nationwide register‐based study in Finland
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Geriatric Psychiatry"
DOI: 10.1002/gps.5018
Abstract: The study aims to determine the prevalence of concomitant use of benzodiazepines and opioids among community‐dwelling older people with or without Alzheimer's disease (AD). An additional aim was to describe the factors associated with prolonged… read more here.
Keywords: use benzodiazepines; concomitant; community dwelling; concomitant use ... See more keywords
Concomitant use of low‐dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4555
Abstract: Case reports and pharmacokinetic studies have suggested that concomitant use of low‐dose methotrexate and nonsteroidal anti‐inflammatory drugs (NSAIDs) may be associated with increased risk of methotrexate toxicity. This study aimed to investigate the risk of… read more here.
Keywords: low dose; methotrexate; use low; dose methotrexate ... See more keywords
Concomitant use of intravenous methylprednisolone to increase retention rate of abatacept in rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Rheumatology International"
DOI: 10.1007/s00296-018-4115-0
Abstract: To investigate whether concomitant use of intravenous methylprednisolone (IVMP) with Abatacept (ABA) contributes to earlier remission and higher drug retention rates. This was a retrospective cohort study to assess the retention rate of ABA in… read more here.
Keywords: concomitant use; retention rate; retention; ivmp ... See more keywords
Practice Patterns of Medications for Patients With Malignant Bowel Obstruction Using a Nationwide Claims Database and the Association Between Treatment Outcomes and Concomitant Use of H2-Blockers/Proton Pump Inhibitors and Corticosteroids With Octreotide.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of pain and symptom management"
DOI: 10.1016/j.jpainsymman.2017.10.019
Abstract: CONTEXT Malignant bowel obstruction impairs the quality of life in patients with advanced cancer. Octreotide, acid-suppressing medications such as H2-receptor antagonists (H2-blockers) and proton pump inhibitors (PPIs), and corticosteroids are often used in combination for… read more here.
Keywords: corticosteroids octreotide; use; bowel obstruction; claims database ... See more keywords
[Concomitant use of nivolumab and immunosuppressants in a renal transplant patient].
Sign Up to like & getrecommendations! Published in 2019 at "Revue des maladies respiratoires"
DOI: 10.1016/j.rmr.2019.08.004
Abstract: INTRODUCTION Immune-checkpoint inhibitors have been approved for first and second line treatments of metastatic non-small cell lung cancer based on the results of several phase III trials. Patients with organ transplantation were excluded from these… read more here.
Keywords: nivolumab immunosuppressants; checkpoint inhibitors; use nivolumab; treatment ... See more keywords
Concomitant Use of Tetrathiafulvalene and 7,7,8,8-Tetracyanoquinodimethane within the Skeletons of Metal-Organic Frameworks: Structures, Magnetism, and Electrochemistry.
Sign Up to like & getrecommendations! Published in 2019 at "Inorganic chemistry"
DOI: 10.1021/acs.inorgchem.9b01000
Abstract: In search of multifunctional metal-organic frameworks (MOFs), redox-active donors and acceptors, namely, tetrathiafulvalene (TTF) and 7,7,8,8-tetracyanoquinodimethane (TCNQ), were concomitantly used as skeletal components with diamagnetic metal nodes (Cd and Zn) to construct unique framework materials.… read more here.
Keywords: tcnq; metal organic; tetracyanoquinodimethane; concomitant use ... See more keywords
Investigation of concomitant use of Alzheimer's disease drugs with sulfonylureas and serious hypoglycemia.
Sign Up to like & getrecommendations! Published in 2020 at "Epidemiology"
DOI: 10.1097/ede.0000000000001263
Abstract: © 2020 Wolters Kluwer Health, Inc. All rights reserved. www.epidem.com | e3 we made it clear in the paper that we had never set out to estimate causal effects, as both sets of correspondents acknowledge.… read more here.
Keywords: causal studies; causal; risk prediction; disease ... See more keywords
Concomitant Use of Nifedipine and Clarithromycin Leading to Pulseless, Bradycardic Arrest.
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000000804
Abstract: To the Editor: A 72-year-old African American woman presented to her primary care physician complaining of cough symptoms. She was subsequently diagnosed with acute bronchitis and prescribed clarithromycin and prednisone. The next day after taking… read more here.
Keywords: blood; bradycardic arrest; use nifedipine; day ... See more keywords
Concomitant use of statins and sodium-glucose co-transporter 2 inhibitors and the risk of myotoxicity reporting - A disproportionality analysis.
Sign Up to like & getrecommendations! Published in 2023 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15711
Abstract: AIM Recent case reports have suggested that sodium-glucose co-transporter 2 inhibitors (SGLT2i) may interact with statins to increase their risk of myotoxicity. We assessed the risk of myotoxicity reporting associated with concomitant use of SGLT2i… read more here.
Keywords: reporting; risk myotoxicity; concomitant use; sglt2i ... See more keywords
Concomitant Gastric Acid Suppressants on the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Clinical Practice"
DOI: 10.1155/2022/3102641
Abstract: Background The influence of concomitant use of gastric acid suppressants (AS) on survival of patients with non-small-cell lung cancer (NSCLC) treated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is inconsistent according to… read more here.
Keywords: acid suppressants; concomitant use; concomitant; gastric acid ... See more keywords